TINI, ANASTASIO
 Distribuzione geografica
Continente #
NA - Nord America 405
EU - Europa 177
AS - Asia 62
AF - Africa 46
Totale 690
Nazione #
US - Stati Uniti d'America 405
IT - Italia 76
CI - Costa d'Avorio 38
IE - Irlanda 34
SE - Svezia 25
SG - Singapore 24
CN - Cina 20
FR - Francia 14
IN - India 8
GB - Regno Unito 7
DE - Germania 6
GE - Georgia 6
GH - Ghana 5
BE - Belgio 4
NL - Olanda 4
FI - Finlandia 3
KR - Corea 3
AT - Austria 2
MA - Marocco 2
KE - Kenya 1
NO - Norvegia 1
PL - Polonia 1
TH - Thailandia 1
Totale 690
Città #
Chandler 77
Des Moines 69
Boardman 40
Abidjan 38
Ashburn 38
Dublin 34
Fairfield 26
Ancona 14
Tolentino 14
Turin 13
Singapore 9
Woodbridge 9
Lawrence 8
Princeton 8
Boydton 7
Cambridge 7
Houston 7
Ann Arbor 6
Falls Church 6
Rome 6
Seattle 6
Washington 6
Accra 5
Jacksonville 5
San Mateo 5
Tbilisi 5
Amsterdam 4
Brussels 4
Los Angeles 4
Norwalk 4
Pune 4
Shenzhen 4
Dallas 3
Kilburn 3
Prineville 3
San Diego 3
Aubervilliers 2
Beijing 2
Catania 2
Gangnam-gu 2
Guangzhou 2
Kochi 2
Milan 2
Pavia 2
Vienna 2
Visakhapatnam 2
Wilmington 2
Bangkok 1
Chiswick 1
Chongqing 1
Fayetteville 1
Helsinki 1
Lianyun 1
Marche 1
Nairobi 1
Ogden 1
Osimo 1
Oslo 1
Prescot 1
Qualiano 1
Resana 1
Seoul 1
Shanghai 1
Warsaw 1
Totale 543
Nome #
Pharmacology of herbal sexual enhancers: A review of psychiatric and neurological adverse effects 86
Is GHB-glucuronide useful as a biomarker for the exogenous use of GHB? 73
Is the issue of Chemsex changing? 65
Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases 61
Nails analysis for drugs used in the context of chemsex: A pilot study 52
Development and validation of a fast ultra-high-performance liquid chromatography tandem mass spectrometry method for determining carbonic anhydrase inhibitors and their metabolites in urine and hair 50
The National Early Warning System, a web-based platform to prevent the spread of New Psychoactive Substances 36
The complex and constantly evolving public health threat of new psychoactive substances in Italy: Addressing the main functions of a national observatory of drugs 31
Biomarkers of 4-hydroxy-N,N-methylpropyltryptamine (4-OH-MPT) intake identified from human hepatocyte incubations 27
In silico and in vitro human metabolism of IOX2, a performance-enhancing doping agent 25
Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives 23
Cannabidiol, ∆9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients 22
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study 21
Development of an enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of methorphan and its O-demethylated metabolite in human blood and its application to post-mortem samples 16
In Vitro and In Vivo Human Metabolism of Ostarine, a Selective Androgen Receptor Modulator and Doping Agent 16
The first LC-MS/MS stereoselective bioanalytical methods to quantitatively detect 9R- and 9S-hexahydrocannabinols and their metabolites in human blood, oral fluid and urine 15
Development of a novel enantioselective high-performance liquid chromatography–mass spectrometry method for the differentiation of dextro- and levo-methorphan and their O-demethylated metabolites in human blood and its application to post-mortem samples 14
Exposure to Synthetic Psychoactive Substances: A Potential Cause for Increased Human Hepatotoxicity Markers 13
null 12
QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid 11
Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for quantitative determination of methylone and some of its metabolites in oral fluid 11
A green analytical method for the simultaneous determination of 17 perfluoroalkyl substances (PFAS) in human serum and semen by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) 10
In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne) 10
Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH 8
Liquid chromatography in forensic toxicology 8
Optimization of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids 8
Analysis of perfluoroalkyl substances ({PFAS}) in conventional and unconventional matrices: Clinical outcomes 7
A new UHPLC-MS/MS method to assess cannabidiol and Δ9-tetrahydrocannabinol and respective metabolites in hair. Application to patients treated with medical cannabis|Sviluppo e validazione di un nuovo metodo in UHPLC-MS/MS per la determinazione di cannabidiolo e di tetraidrocannabinolo e relativi metaboliti in matrice pilifera. Applicazione su pazienti trattati con cannabis medica 6
UHPLC-MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers 6
Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids 6
The targeted analysis of New Psychoactive Substances in oral fluid through chromatographic-spectrometric methods: review of recent findings 2
Totale 751
Categoria #
all - tutte 5.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 19 0 11 0 13 8
2021/202283 0 7 1 2 2 7 0 7 7 9 22 19
2022/2023254 17 25 13 15 13 81 3 19 37 4 22 5
2023/2024199 15 6 26 32 21 17 4 5 7 11 14 41
2024/2025164 72 59 31 2 0 0 0 0 0 0 0 0
Totale 751